As filed with the Securities and Exchange Commission on December 9, 2021
No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Forbion European Acquisition Corp.
(Exact name of registrant as specified in its charter)
| | | | |
Cayman Islands | | 6770 | | N/A |
(State or other jurisdiction of incorporation or organization) | | (Primary Standard Industrial Classification Code Number) | | (I.R.S. Employer Identification No.) |
4001 Kennett Pike, Suite 302
Wilmington, Delaware 19807
United States of America
Tel: +1 (302) 273 0765
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
Cogency Global Inc.
122 East 42nd Street, 18th Floor
New York, NY
United States of America
Tel: +1 (212) 947 7200
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)
Copies to:
| | | | | | |
Leo Borchardt Reuven B. Young Davis Polk & Wardwell London LLP 5 Aldermanbury Square London EC2V 7HR United Kingdom Tel: +44 20 7418 1300 | | Derek J. Dostal Yasin L. Keshvargar Davis Polk & Wardwell LLP 450 Lexington Avenue New York, NY 10017 United States of America Tel: +1 (212) 450-4000 | | Christian O. Nagler Kirkland & Ellis LLP 601 Lexington Avenue New York, NY 10022 United States of America Tel: +1 (212) 446-4800 | | Alex Lloyd Kirkland & Ellis LLP 200 Clarendon Street Boston, MA 02116 United States of America Tel: +1 (617) 385-7500 |
Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), check the following box: ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ File Number 333-261308
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | |
Large accelerated filer | | ☐ | | Accelerated filer | | ☐ |
| | | |
Non-accelerated filer | | ☒ | | Smaller reporting company | | ☒ |
| | | |
| | | | Emerging growth company | | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
CALCULATION OF REGISTRATION FEE
| | | | | | | | |
|
Title Of Each Class Of Securities To Be Registered | | Amount To Be Registered | | Proposed Maximum Offering Price Per Security(1) | | Proposed Maximum Aggregate Offering Price(1) | | Amount Of Registration Fee |
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant(2) | | 1,150,000 units | | $ 10.00 | | $ 11,500,000 | | $ 1,066.05 |
Class A ordinary shares included as part of the units(3) | | 1,150,000 shares | | — | | — | | — (4) |
Redeemable warrants included as part of the units(3) | | 383,333 warrants | | — | | — | | — (4) |
Class A ordinary shares issuable upon exercise of the redeemable warrants included as part of the units | | 383,333 shares | | $ 11.50 | | $ 4,408,329.50 | | $ 408.65 (5) |
Total | | | | | | $ 15,908,329.50 | | $ 1,474.70 (6) |
|
|
(1) | Estimated solely for the purpose of calculating the registration fee. |
(2) | Represents only the additional number of securities being registered. Does not include the securities that the Registrant previously registered on its Registration Statement on Form S-1, as amended (File No. 333-261308). Includes 1,150,000 units, consisting of 1,150,000 Class A ordinary shares and 383,333 redeemable warrants (including 150,000 units, consisting of 150,000 Class A ordinary shares and 50,000 redeemable warrants, which may be issued upon exercise of a 45-day option granted to the underwriters to cover over-allotments, if any). |
(3) | Pursuant to Rule 416(a), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share sub-divisions, share dividends or similar transactions. |
(4) | No fee pursuant to Rule 457(g). |
(5) | Calculated pursuant to Rule 457(g) under the Securities Act, based on the exercise price of the warrants. |
(6) | The Registrant previously registered securities having a proposed maximum aggregate offering price of $159,083,329.50 on its Registration Statement on Form S-1, as amended (File No. 333-261308), which was declared effective by the Securities and Exchange Commission on December 9, 2021. In accordance with Rule 462(b) under the Securities Act, an additional number of securities having a proposed maximum offering price of $15,908,329.50 is hereby registered, which includes securities issuable upon the exercise of the underwriters’ over-allotment option. |
This Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) promulgated under the Securities Act.